Physician profile
Jesse E Phillips
NPI 1457351983
$2,921.66
in general payments reported to CMS, 2019-2025
26 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $239 · 2021: $1,236 · 2022: $214 · 2023: $305 · 2024: $215 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,068.72 | 2020-2021 | |
| Genzyme Corporation | $366.17 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $181.07 | 2021-2025 | Hyqvia, Cuvitru |
| Fisher & Paykel Healthcare INC | $167.42 | 2019-2023 | Fisher & Paykel Healthcare |
| Regeneron Healthcare Solutions, INC. | $150.52 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $117.42 | 2022-2025 | Nucala |
| Acclarent, INC | $114.41 | 2019 | |
| Livanova USA, INC. | $107.25 | 2019 | |
| Smith+Nephew, INC. | $105.08 | 2019-2020 | |
| Optinose US, INC. | $73.25 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $62.36 | 2019-2024 | |
| Intersect Ent, INC. | $51.51 | 2019-2021 | |
| Insmed, INC. | $47.18 | 2025 | Arikayce |
| Jazz Pharmaceuticals INC. | $45.75 | 2020-2021 | |
| Octapharma USA, INC. | $43.17 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $40.06 | 2025 | Zepbound |
| Csl Behring | $24.26 | 2022 | |
| Alk-Abello, INC | $21.88 | 2021 | |
| Horizon Therapeutics Plc | $20.24 | 2021 | |
| Hologic Sales and Service, LLC | $17.95 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.21 | 2022 | |
| Cochlear Americas | $16.92 | 2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Kaleo, INC. | $16.50 | 2022 | |
| Aerin Medical INC. | $16.49 | 2020 | |
| Stryker Corporation | $14.77 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.